Catalent Inc (MEX:CTLT)
MXN 1020 0 (0%) Market Cap: 231.55 Bil Enterprise Value: 324.58 Bil PE Ratio: 0 PB Ratio: 3.23 GF Score: 81/100

Catalent Inc at Barclays Global Healthcare Conference Transcript

Mar 12, 2019 / 06:35PM GMT
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

Great. Good afternoon, everybody. Thanks for joining us for Catalent's presentation. I'm Jack Meehan, the Barclays' life science tools and diagnostics analyst. Pleased to be joined by our presenter today, CFO Wetteny Joseph. Before we kick it off, we're going to do 3 audience response questions quickly. So use the BlackBerry device in front of you. We'll run through them quick. First, what do you view as Catalent's organic growth profile over the next 3 years?

Wetteny N. Joseph
Catalent, Inc. - Senior VP & CFO

Yes, sure, I'll...

Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

You're not allowed to answer yet. We're going to compare your answers later, towards the audience thing.

Wetteny N. Joseph;Jack Meehan
Catalent, Inc. - Senior VP & CFO;Barclays Bank PLC, Research Division - VP & Senior

Okay, sorry.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot